|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Concert Pharmaceuticals, Inc. (CNCE) |
|
|
$8.37 0.00 (0.00%) as of 4:30 Fri 3/3
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,940,000 |
Market
Cap: |
401.26(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$8.37 - $8.37 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company that is developing CTP-543, a Janus Kinase 1 and Janus Kinase 2 inhibitor that Co. discovered through the application of its DCE Platform® (deuterated chemical entity platform). Co. is evaluating CTP-543 in a Phase 3 clinical program for the treatment of alopecia areata, a serious autoimmune dermatological condition. In addition to its wholly-owned development programs, Co. has entered into collaborative arrangements with companies to develop deuterium-modified versions of their marketed products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
81,977 |
Total Sell Value |
$0 |
$0 |
$0 |
$653,253 |
Total People Sold |
0 |
0 |
0 |
6 |
Total Sell Transactions |
0 |
0 |
0 |
14 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Barrett Ronald W |
Director |
|
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,125 |
5,125 |
|
- |
|
Tung Roger D |
Chief Executive Officer |
|
2021-02-17 |
4 |
AS |
$7.20 |
$97,056 |
D/D |
(13,480) |
808,578 |
|
-37% |
|
Munsie Jeffrey A |
Chief Legal Officer |
|
2021-02-16 |
4 |
AS |
$7.32 |
$27,545 |
D/D |
(3,763) |
46,153 |
|
-41% |
|
Becker Marc A. |
Chief Financial Officer |
|
2021-02-16 |
4 |
AS |
$7.32 |
$27,545 |
D/D |
(3,763) |
71,371 |
|
-41% |
|
Cassella James V |
Chief Development Officer |
|
2021-02-16 |
4 |
AS |
$7.32 |
$27,545 |
D/D |
(3,763) |
94,064 |
|
-41% |
|
Stuart Nancy |
Chief Operating Officer |
|
2021-02-16 |
4 |
AS |
$7.32 |
$44,279 |
D/D |
(6,049) |
173,280 |
|
-41% |
|
Stuart Nancy |
Chief Operating Officer |
|
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
21,700 |
179,329 |
|
- |
|
Cassella James V |
Chief Development Officer |
|
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
21,700 |
97,827 |
|
- |
|
Becker Marc A. |
Chief Financial Officer |
|
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
21,700 |
75,134 |
|
- |
|
Munsie Jeffrey A |
Chief Legal Officer |
|
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
21,700 |
49,916 |
|
- |
|
Tung Roger D |
Chief Executive Officer |
|
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
69,300 |
822,058 |
|
- |
|
Hutt Peter Barton |
Director |
|
2020-08-31 |
4 |
OE |
$3.79 |
$13,413 |
D/D |
3,539 |
7,963 |
|
- |
|
Becker Marc A. |
Chief Financial Officer |
|
2020-08-17 |
4 |
AS |
$10.24 |
$29,440 |
D/D |
(2,875) |
53,434 |
|
16% |
|
Cassella James V |
Chief Development Officer |
|
2020-08-17 |
4 |
AS |
$10.37 |
$45,151 |
D/D |
(4,354) |
76,127 |
|
16% |
|
Stuart Nancy |
Chief Operating Officer |
|
2020-06-22 |
4 |
S |
$11.34 |
$116,694 |
D/D |
(10,295) |
157,629 |
|
15% |
|
Stuart Nancy |
Chief Operating Officer |
|
2020-06-22 |
4 |
OE |
$3.79 |
$80,492 |
D/D |
21,238 |
167,924 |
|
- |
|
Tung Roger D |
Chief Executive Officer |
|
2020-03-13 |
4 |
OE |
$3.79 |
$55,338 |
D/D |
14,601 |
752,758 |
|
- |
|
Auchincloss Thomas G |
Director |
|
2020-03-12 |
4 |
B |
$8.52 |
$12,773 |
D/D |
1,500 |
6,500 |
2.39 |
31% |
|
Tung Roger D |
Chief Executive Officer |
|
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
101,100 |
738,157 |
|
- |
|
Stuart Nancy |
Chief Operating Officer |
|
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
45,363 |
146,686 |
|
- |
|
Cassella James V |
Chief Development Officer |
|
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
28,216 |
80,481 |
|
- |
|
Munsie Jeffrey A |
Chief Legal Officer |
|
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
28,216 |
28,216 |
|
- |
|
Becker Marc A. |
Chief Financial Officer |
|
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
28,216 |
56,309 |
|
- |
|
Auchincloss Thomas G |
Director |
|
2020-02-03 |
4 |
B |
$10.91 |
$10,910 |
D/D |
1,000 |
5,000 |
2.39 |
-8% |
|
Tung Roger D |
Chief Executive Officer |
|
2019-12-04 |
4 |
D |
$7.61 |
$58,057 |
D/D |
(7,629) |
637,057 |
|
- |
|
238 Records found
|
|
Page 4 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|